Enzyvia, a division of JBS United, reports that Bob Dowden has joined the company as its managing director. Dowden is a seasoned executive with experience in the animal health, pharmaceutical and medical-device industries. In his 30+ year career, Dowden has held various marketing, human resources and senior management positions with the medical device manufacturer, Guidant Corporation (which was purchased by Boston Scientific); Eli Lilly and Company, and its animal health leader, Elanco.
Dowden’s combined leadership experience in these diverse international companies and his knowledge of the animal health industry made him the perfect candidate to lead Enzyvia into the future, company officials note.
Enzyvia is responsible for marketing and commercializing various enzyme products, including OptiPhos, an advanced phytase that allows livestock to access more of the phosphorus in their grain feed, and Enspira, a blend of enzymes to help poultry get more from their diets and improve their health.
Enzyvia sells its products internationally and company officials say it is poised to grow substantially as the advanced bio-catalyst market continues to gain interest around the world and more benefits are realized from their use.
Dowden attended Purdue University, where he earned both a Bachelor of Science degree and a Master of Science degree. His international business experience, which includes living and working in Singapore for two years, will be especially beneficial as the company expands, officials note.
Source: JBS United